Considering the fact that numerous publications indicate musculoskeletal problems and low back pain in patients affected by COVID-19 [15,16,17,18] and that degeneration of the IVD leads to “access” to the vasculature raises the question of whether SARS-CoV-2 is also found in IVD and might target the ACE2 available here. Here, ACE2 is linked to COVID-19.